Evaluation of fibrinogen self-assembly: Role of its αC region

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 12, 2010, Pages 2727-2735

  Koo, J ^a   Rafailovich, M H ^a   Medved, L ^b   Tsurupa, G ^b   Kudryk, B J ^c   Liu, Y ^a   Galanakis, D K ^d  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NEW YORK BLOOD CENTER   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

Fibrinogen; Fibrinogen C; Fibrinogen adsorption; Fibrinogen fiber stiffness; Fibrinogen fibers; Fibrinogen self assembly

Indexed keywords

BIOMATERIAL; FIBRINOGEN; MONOCLONAL ANTIBODY; SILICON DIOXIDE;

ADSORPTION; ARTICLE; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DOMAIN; SURFACE PROPERTY; YOUNG MODULUS;

ADSORPTION; ANTIBODIES, MONOCLONAL; FIBRINOGEN; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; RECOMBINANT PROTEINS; SOLUTIONS; SURFACE PROPERTIES;

EID: 78650019483     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04072.x     Document Type: Article

References (37)

1. Weisel J. Fibrinogen and fibrin. Adv Protein Chem 2005; 70: 247-99.
2. Medved L, Weisel JW. Recommendations for nomenclature on fibrinogen and fibrin. Fibrinogen and Factor XIII Subcommittee of Scientific Standardization Committee of International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 355-9.
3. Tsurupa G, Tsonev L, Medved L. Structural organization of the fibrin(ogen) αC-domain. Biochemistry 2002; 41: 6449-59.
4. Litvinov RI, Yakovlev S, Tsurupa G, Gorkun OV, Medved L, Weisel J. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry 2007; 46: 9133-42.
5. Medved LV, Gorkun OV, Privalov PL. Structural organization of C-terminal parts of fibrinogen A alpha-chains. FEBS Lett 1983; 160: 291-5.
6. Veklich YI, Gorkun O, Medved L, Nieuwenhuizen W, Weisel J. Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. J Biol Chem 1993; 268: 13577-85.
7. Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci 2001; 936: 312-27.
8. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53: 195-229.
9. Medved L, Tsurupa G, Yakovlev S. Conformational changes upon conversion of fibrinogen into fibrin. The mechanisms of exposure of cryptic sites. Ann N Y Acad Sci 2001; 936: 185-204.
10. Ugarova TP, Budzynski AZ, Shattil SJ, Ruggeri ZM, Ginsberg MH, Plow EF. Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIa. Biol Chem 1993; 268: 21080-7.
11. Bridges A, García A. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. J Diabetes Sci Technol 2008; 2: 984-94.
12. Tang L. Mechanisms of fibrinogen domains: biomaterial interactions. J Biomater Sci Polym Ed 1998; 9: 1257-66.
13. Ugarova TP, Solovjov DA, Zhang L, Loukinov DI, Yee VC, Medved LV, Plow EF. Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen. J Biol Chem 1998; 273: 22519-27.
14. Vidal B, Serrano AL, Tjwa M, Suelves M, Ardite E, De Mori R, Baeza-Raja B, Martínez de Lagrán M, Lafuste P, Ruiz-Bonilla V, Jardí M, Gherardi R, Christov C, Dierssen M, Carmeliet P, Degen JL, Dewerchin M, Muñoz-Cánoves P. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev 2008; 22: 1747-52.
15. Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K. The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Environ Monit 2007; 204: 571-82.
16. Akassoglou K, Adams RA, Bauer J, Mercado P, Tseveleki V, Lassmann H, Probert L, Strickland S. Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. Proc Natl Acad Sci U S A 2004; 101: 6698-703.
17. Schachtrup C, Ryu J, Helmrick M, Vagena E, Dennis Galanakis DK, Degen J, Margolis R, Akassoglou K. Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. Neuroscience 2010; 30: 5843-54.
18. Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. J Struct Biol 1995; 115: 88-101.
19. Stewart G, Niewiarowski S. Nonenzymatic polymerization of fibrinogen by protamine sulfate. Biochim Biophys Acta 1969; 194: 462-9.
20. Stryer L, Cohen C, Langridge RL. Axial period of fibrinogen and fibrin. Nature 1963; 197: 793-4.
21. Rudee ML, Price TM. The initial stages of adsorption of plasma derived proteins on artificial surfaces in a controlled flow environment. J Biomed Mater Res 1985; 19: 57-66.
22. Wigren R, Elwing H, Erlandsson R, Welin S, Lundstrom I. Structure of adsorbed fibrinogen obtained by scanning force microscopy. FEBS Lett 1991; 280: 225-8.
23. Evans-Nguyen KM, Fuirrere RR, Fitchett BD, Tolles LR, Conboy JC, Schoenfisch MH. Changes in adsorbed fibrinogen upon conversion to fibrin. Langmuir 2006; 22: 5115-21.
24. Ohta R, Saito N, Ishizaki T, Takai O. Visualization of human plasma fibrinogen adsorbed on highly oriented pyrolytic graphite by scanning probe microscopy. Surf Sci 2006; 600: 1674-8.
25. Geer CB, Rus IA, Lord ST, Schoenfisch MH. Surface-dependent fibrinopeptide A accessibility to thrombin. Acta Biomater 2007; 3: 663-8.
26. Evans-Nguyen KM, Schoenfisch MH. Fibrin proliferation t model surfaces: influence of surface properties. Langmuir 2005; 21: 1691-4.
27. Whitlock PW, Clarson SJ, Retzinger GS. Fibrinogen adsorbs from aqueous media to microscopic droplets of poly(dimethylsiloxane) and remains coagulable. J Biomed Mater Res 1999; 45: 55-61.
28. Marchin K, Berrie C. Conformational changes in the plasma protein fibrinogen upon adsorption to graphite and mica investigated by atomic force microscopy. Langmuir 2003; 19: 9883-8.
29. Galanakis DK, Neerman-Arbez M, Kudryk B, Henschen A. Decreased plasmin resistance by clots of a homophenotypicAa R16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release). Blood Coagul Fibrinolysis 2010; 21: 135-9.
30. Mosesson MW, Galanakis DK, Finlayson JS. Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives. J Biol Chem 1974; 249: 4656-64.
31. Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the alpha C domains of fibrin in clot formation. Biochemistry 1994; 33: 6986-97.
32. Mosesson M, Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 1966; 5: 2829-35.
33. Koo J, Park S, Satija S, Tikhonov A, Sokolv JC, Refailovich M, Kog T. Characterization of Langmuir-Blodgett organoclay films using X-ray reflectivity and atomic force microscopy. J Colloid Interface Sci 2008; 318: 103-9.
34. Mishra S, Shimpi N. Studies on mechanical, thermal, and flame retarding Properties of Polybutadiene Rubber (PBR) Nanocomposites. Polym Plast Technol Eng 2008; 47: 72-81.
35. Sit PS, Marchant RE. Surface-dependent conformations of human fibrinogen observed by atomic force microscopy under aqueous conditions. Thromb Haemost 1999; 82: 1053-60.
36. Collet J-P, Moen JL, Veklich YI, Gorkun OV, Lord ST, Weisel JW. The elasticity of an individual fibrin fiber in a clot. PNAS 2005; 102: 9133-7.
37. Medved L, Gorkun OV, Manyakov VF, Belitser VA. The role of fibrinogen alpha C-domains in the fibrin assembly process. FEBS Lett 1985; 181: 109-12.